Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
2.45
↓ 91% below average
Average (8y)
25.86
Historical baseline
Range
High:83.08
Low:1.64
CAGR
-28.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.45 | +24.1% |
| 2023 | 1.97 | +20.6% |
| 2022 | 1.64 | -65.0% |
| 2021 | 4.67 | -54.5% |
| 2020 | 10.27 | -84.8% |
| 2019 | 67.63 | -18.6% |
| 2018 | 83.08 | +215.2% |
| 2017 | 26.36 | -23.9% |
| 2016 | 34.65 | - |